Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Angiogenesis
Published in: Angiogenesis 1/2001

01-03-2001

CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism

Authors: Lillian B. Nanney, Barbara D. Wamil, Jeffrey Whitsitt, Nancy L. Cardwell, Jeffrey M. Davidson, He-Ping Yan, Carl G. Hellerqvist

Published in: Angiogenesis | Issue 1/2001

Login to get access
Metadata
Title
CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism
Authors
Lillian B. Nanney
Barbara D. Wamil
Jeffrey Whitsitt
Nancy L. Cardwell
Jeffrey M. Davidson
He-Ping Yan
Carl G. Hellerqvist
Publication date
01-03-2001
Publisher
Kluwer Academic Publishers
Published in
Angiogenesis / Issue 1/2001
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1023/A:1016752925761

Other articles of this Issue 1/2001

Angiogenesis 1/2001 Go to the issue

OriginalPaper

TGFβ is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells

OriginalPaper

Platelets and vascular endothelial growth factor (VEGF): A morphological and functional study

OriginalPaper

An ex vivo angiogenesis assay utilizing commercial porcine carotidartery: Modification of the rat aortic ring assay

OriginalPaper

Mg++-induced endothelial cell migration: Substratum selectivity and receptor-involvement

OriginalPaper

Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro

OriginalPaper

Production and characterization of a Tie2 agonist monoclonal antibody
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits